Ylva Flodérus

Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene

Ylva Flodérus, PM Shoolingin‐Jordan, Pauline Harper · Clinical Genetics · 2002 · 90 citations

Life Sciences, Genetics, Molecular Genetics +15

Erythropoietic protoporphyria in Sweden: demographic, clinical, biochemical and genetic characteristics

Staffan Wåhlin, Ylva Flodérus, Per Stål et al. · Journal of Internal Medicine · 2010 · 85 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

Variations in Porphobilinogen and 5-Aminolevulinic Acid Concentrations in Plasma and Urine from Asymptomatic Carriers of the Acute Intermittent Porphyria Gene with Increased Porphyrin Precursor Excretion

Ylva Flodérus, Eliane Sardh, Christer Möller et al. · Clinical Chemistry · 2006 · 67 citations · Full text

Life Sciences, Biochemistry, Excretion +15

Erythrocyte catechol‐O‐methyltransferase activity in a Swedish population

Ylva Flodérus, Svante B. Ross, Lennart Wetterberg · Clinical Genetics · 1981 · 62 citations

Life Sciences, Biochemistry, Genetics +7

Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals

Mattias Lissing, Daphne Vassiliou, Ylva Flodérus et al. · Journal of Internal Medicine · 2022 · 59 citations · Full text

Medicine, Internal Medicine, Oncology +17